Richard A. Barasch - 17 Mar 2023 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Richard Barasch
Issuer symbol
TOI
Transactions as of
17 Mar 2023
Net transactions value
+$27,495
Form type
4
Filing time
21 Mar 2023, 21:01:19 UTC
Previous filing
08 Apr 2024
Next filing
26 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Purchase $5,500 +10,000 +4.8% $0.5500 217,193 17 Mar 2023 Direct
transaction TOI Common stock Purchase $28.55 +52 +0.02% $0.5490 217,245 17 Mar 2023 Direct
transaction TOI Common stock Purchase $110 +200 +0.09% $0.5480 217,445 17 Mar 2023 Direct
transaction TOI Common stock Purchase $5,471 +9,948 +4.6% $0.5500 227,393 17 Mar 2023 Direct
transaction TOI Common stock Purchase $4,210 +7,654 +3.4% $0.5500 235,047 17 Mar 2023 Direct
transaction TOI Common stock Purchase $1,176 +2,146 +0.91% $0.5480 237,193 17 Mar 2023 Direct
transaction TOI Common stock Purchase $5,500 +10,000 +4.2% $0.5500 247,193 17 Mar 2023 Direct
transaction TOI Common stock Purchase $5,500 +10,000 +4% $0.5500 257,193 17 Mar 2023 Direct
holding TOI Common stock 8 17 Mar 2023 By Family Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities held by the Helen Barasch Family Trust #1 (the "Trust"), of which the reporting person is the investment manager and has voting and dispositive power over the securities held by the Trust, but disclaims beneficial ownership of these shares except to any pecuniary interest therein.